dostęp otwarty

Tom 19, Nr 3 (2015)
ORIGINAL PAPERS
Opublikowany online: 2015-09-29
Pobierz cytowanie

Trends for beta-blockers use in a large cohort of Polish hypertensive patients — Pol-Fokus Study

Aleksander Prejbisz, Marek Klocek, Jerzy Gąsowski, Roman Topór-Mądry, Wiktoria Leśniak, Marek Kabat, Danuta Czarnecka, Kalina Kawecka-Jaszcz, Krzysztof Narkiewicz, Andrzej Januszewicz
DOI: 10.5603/AH.2015.0015
·
Arterial Hypertension 2015;19(3):120-128.

dostęp otwarty

Tom 19, Nr 3 (2015)
ORIGINAL PAPERS
Opublikowany online: 2015-09-29

Streszczenie

Background Beta-blockers remain one of the most frequently prescribed antihypertensive drug classes. The aim of the analysis was to evaluate characteristics of patients treated with beta-blockers and factors associated with the treatment of beta-blockers.

Material and methods We analysed the data from the large cross-sectional study evaluating 12,375 patients treated for hypertension for at least one year.

Results Overall, 7080 patients (57.2% of the whole group) were treated with beta-blockers. The rate of use of beta-blockers was higher in patients with diabetes (62.9 vs 55.6%), coronary artery disease (72.2 vs 46.4%), previous myocardial infarction (82.3 vs 54.1%), heart failure (73.1 vs 53.3%) and arrhythmias (73.1 vs 51.1%) than in patients without those conditions (all comparisons p < 0.001). Beta-blockers were used less frequently among patients with asthma/COPD than without asthma/COPD (54.0 vs 58.0%; p = 0.017). In patients aged 40 years and less, the compelling indications for these agents were found only in 21.7% of patients. In patients aged 40–65 years, none of compelling indications was found in 41.3% of patients. In patients 65 years or more, the most frequent compelling indications were coronary artery disease, previous myocardial infarction and heart failure, which were present in 70.1% of patients.

Conclusions High utilization rate of beta-blockers in patients with hypertension, only second to renin-angiotensin blockers, has been shown. In middle age and, especially, in older patients it might reflect high cardiovascular burden of those patients, including coexistence of established cardiac disease. In younger patients beta-blockers are used more frequently with none of the compelling indications present.

Streszczenie

Background Beta-blockers remain one of the most frequently prescribed antihypertensive drug classes. The aim of the analysis was to evaluate characteristics of patients treated with beta-blockers and factors associated with the treatment of beta-blockers.

Material and methods We analysed the data from the large cross-sectional study evaluating 12,375 patients treated for hypertension for at least one year.

Results Overall, 7080 patients (57.2% of the whole group) were treated with beta-blockers. The rate of use of beta-blockers was higher in patients with diabetes (62.9 vs 55.6%), coronary artery disease (72.2 vs 46.4%), previous myocardial infarction (82.3 vs 54.1%), heart failure (73.1 vs 53.3%) and arrhythmias (73.1 vs 51.1%) than in patients without those conditions (all comparisons p < 0.001). Beta-blockers were used less frequently among patients with asthma/COPD than without asthma/COPD (54.0 vs 58.0%; p = 0.017). In patients aged 40 years and less, the compelling indications for these agents were found only in 21.7% of patients. In patients aged 40–65 years, none of compelling indications was found in 41.3% of patients. In patients 65 years or more, the most frequent compelling indications were coronary artery disease, previous myocardial infarction and heart failure, which were present in 70.1% of patients.

Conclusions High utilization rate of beta-blockers in patients with hypertension, only second to renin-angiotensin blockers, has been shown. In middle age and, especially, in older patients it might reflect high cardiovascular burden of those patients, including coexistence of established cardiac disease. In younger patients beta-blockers are used more frequently with none of the compelling indications present.

Pobierz cytowanie

Słowa kluczowe

beta-blockers, hypertension, guidelines

Informacje o artykule
Tytuł

Trends for beta-blockers use in a large cohort of Polish hypertensive patients — Pol-Fokus Study

Czasopismo

Arterial Hypertension

Numer

Tom 19, Nr 3 (2015)

Strony

120-128

Data publikacji on-line

2015-09-29

DOI

10.5603/AH.2015.0015

Rekord bibliograficzny

Arterial Hypertension 2015;19(3):120-128.

Słowa kluczowe

beta-blockers
hypertension
guidelines

Autorzy

Aleksander Prejbisz
Marek Klocek
Jerzy Gąsowski
Roman Topór-Mądry
Wiktoria Leśniak
Marek Kabat
Danuta Czarnecka
Kalina Kawecka-Jaszcz
Krzysztof Narkiewicz
Andrzej Januszewicz

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Czasopismo Nadciśnienie Tętnicze dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl